Evercore's Street-high initiation from a top-tier firm is a powerful bullish signal, but the cluster of insider sales and downward annual EPS revisions create a tug-of-war. The stock's setup is constructive near-term given improving quarterly estimates, but the insider activity warrants monitoring for further selling.
Price Chart
Executive Summary
Evercore ISI Group initiated coverage on KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) at Outperform with a $34 price target, implying 14.3% upside from the current $29.74. The firm, with a 58% accuracy rate on 2,859 calls and an average return of 4.7%, is the most credible new entrant covering the stock. Consensus is heavily bullish — 12 of 14 analysts rate it Buy/Strong Buy, with only 2 Holds and no Sells. The mean price target of $30.29 suggests modest 1.9% upside, making Evercore's $34 target the highest on the Street. Recent insider selling by multiple C-suite officers in September 2026 (totaling ~$511k) diverges from the bullish analyst signal, introducing caution. EPS estimates for the current fiscal year have been revised down twice in the past 30 days, while the current quarter saw two upward revisions. The initiation from a high-accuracy firm at a Street-high target is a notable positive signal, but insider sales and downward annual EPS revisions temper the outlook.
Impact Score
Consensus & Targets
Consensus is heavily bullish: 6 Strong Buy, 6 Buy, 2 Hold, 0 Sell, 0 Strong Sell (14 analysts). The overwhelming majority of analysts are positive, reflecting broad institutional confidence in the company's trajectory.
Current price: $29.74. Mean target: $30.29 (implied upside 1.9%). Median: $30. High: $32 (BTIG). Low: $28. Evercore's $34 target is above the high end of the existing range, representing a 14.3% upside from current levels and a 12.3% premium to the mean.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-20 | Evercore ISI Group | initiate | Outperform | $34.00 |
| 2026-09-15 | BTIG | reiterate | Buy | — |
| 2026-09-02 | BTIG | reiterate | Buy | $32.00 |
| 2026-08-10 | JP Morgan | initiate | Overweight | $30.00 |
| 2026-07-21 | Oppenheimer | initiate | Perform | — |
| 2026-07-15 | BTIG | maintain | Buy | — |
| 2026-04-09 | Goldman Sachs | maintain | Neutral | $17.00 |
| 2026-04-07 | BTIG | reiterate | Buy | $32.00 |
| 2026-03-25 | BTIG | reiterate | Buy | — |
| 2026-03-18 | BTIG | reiterate | Buy | — |
In the past 30 days, there has been 1 upgrade (Evercore's initiation) and 0 downgrades. EPS revisions show a mixed picture: the current quarter (0q) saw 2 upward revisions in the past 7 days and 2 in the past 30 days, while the current fiscal year (0y) saw 2 downward revisions in the past 30 days. Near-term estimates are improving, but full-year estimates are being trimmed.
Firm Track Record — Evercore ISI Group
Evercore ISI Group accuracy: 58% on 2859 calls | avg return: 4.7%
Industry benchmark: mean 51% ± 10%. Top tier: ≥61% (mean + 1σ). Based on 3 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Wells Fargo | 33% | 1/3 | -4.8% | below average |
| Goldman Sachs | 0% | 0/3 | -34% | below average |
| Piper Sandler | 0% | 0/2 | -31.9% | below average |
Evercore ISI Group has a 58% accuracy rate on 2,859 scored calls with an average return of 4.7%. This is the best track record among firms covering KMTS, compared to Wells Fargo (33% on 3 calls), Goldman Sachs (0% on 3 calls), and Piper Sandler (0% on 2 calls). Evercore's initiation carries significantly more weight than other recent coverage starts.
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0y | $-2.45 | $-2.46 — $-2.44 | $140.9M | ↑0 ↓0 |
| 0q | $-0.60 | $-0.61 — $-0.60 | $32.0M | ↑2 ↓0 |
| +1y | $-2.06 | $-2.06 — $-2.05 | $195.9M | ↑0 ↓0 |
| +1q | $-0.57 | $-0.58 — $-0.57 | $35.4M | ↑0 ↓0 |
Cross-Platform Signals
Insider trades show five sales in September 2026 totaling ~$511k by C-suite officers (COHEN RAYMOND W, Kwo Elizabeth, Ladone Mary Kay, Reilly Kevin C, Hanley Conor). These are not 10b5-1 pattern sales and represent a bearish divergence from the bullish analyst signal. No congressional trades, institutional changes, or short interest data are available. The insider selling is a notable contra-indicator that partially offsets the bullish initiation.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 144 | $29.78 | awaiting T+20 | — | $29.99 (+0.71%) |
Oct 27, 2026 today | 144 | $29.78 | awaiting T+20 | — | $29.99 (+0.71%) |
Oct 22, 2026 6d ago | Insider Cluster | $28.76 | awaiting T+20 | — | $29.99 (+4.28%) |
Oct 20, 2026 7d ago | 144 | $27.31 | awaiting T+20 | — | $29.99 (+9.81%) |
Oct 20, 2026 7d ago | ANALYST-UPGRADE | $28.28 | awaiting T+20 | — | $29.99 (+6.05%) |
Sep 30, 2026 27d ago | 144 | $27.12 | awaiting T+20 | — | $29.99 (+10.60%) |
Sep 14, 2026 6w ago | Press Release | $25.18 $26.97 | ▲ +7.11% | ▲ +4.39% | $29.99 (+19.10%) |
Sep 10, 2026 6w ago | Insider Cluster | $22.85 $26.98 | ▲ +18.07% | ▲ +16.21% | $29.99 (+31.25%) |
Sep 10, 2026 6w ago | Press Release | $23.57 $25.77 | ▲ +9.33% | ▲ +7.21% | $29.99 (+27.24%) |
Aug 31, 2026 8w ago | Press Release | $25.12 $28.29 | ▲ +12.62% | ▲ +12.30% | $29.99 (+19.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers